Home » Cepheid Qualitative HIV-1 Test Receives CE Mark

Cepheid Qualitative HIV-1 Test Receives CE Mark

Apr 16, 2015

NEW YORK (GenomeWeb) – Cepheid announced today that its qualitative HIV-1 assay has achieved CE-IVD status. The assay, called Xpert HIV-1 Qual, runs on the firm's GeneXpert platform and detects nucleic acid of the virus from blood samples in around 90 minutes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Prize for Five

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Sure, Blame the Test

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

This Week in Genome Research

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Low Down Syndrome Rates in Iceland

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.

What's Popular?

In PCR

  1. FDA Grants EUA for Columbia University's Zika Test

  2. FDA Clears iCubate System, Bloodstream Infection Assay

  3. Biofortuna to Further Commercialize Genotyping Assays With £1.6M Financing

  4. Curetis Posts 9 Percent Drop in H1 Revenues

  5. Single-Color Digital PCR Method Shows Promise for Blood-Based Cancer Monitoring

    Premium

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.